Azopyrazolone
1499
(C6Hþ5 ), 128 (C8H5N2þ), 203 (M–C8H5N2)þ, etc. The base peak and m/z 93 and the
absence of (M–N2) peak clearly point to a hydrazone [18] structure rather than an azo
structure. Based on the mass spectrum, the structure of LH has been confirmed. Mass
spectra of the two copper complexes showed the parent ion at 488 and 528 for the
brown colored and green colored complexes, respectively. Both spectra showed
fragment peaks due to the detachment of C8H5N2(phthalazinyl) and
C4N2OH3(pyrazolonyl). The mass spectrum of the brown colored copper complex
agreed well with the structural formula [CuL(OAc)(H2O)2]. The values of prominent
m/z peaks were 488 (Mþ), 469 (M–H2O), 450 (M–twoH2O), 301 [M–(C8H5N2 þ OAc)],
279
(M–C8H5N2–OAc–H2O),
203
[M–(C8H5N2 þ C4N2OH3 þ OAc)],
243
[M–(C8H5N2 þ C5N2H3–H2O)]
–
base peak, 185 [M–(C8H5N2 þ C5N2H3 þ H2O–
OAc)], 92 (C6H5NþH), 77 (C6Hþ5 ), etc. Additional M þ 1, M þ 2, etc. peaks were
also present. The mass spectrum of green copper complex agreed well with the
structural formula [CuLH(OAc)2H2O]. The prominent m/z values are 528 (Mþ),
474 (M–CH3COO),
416
(M–2xCH3COO),
154-Basepeak
[þM–
(2xCH3COO þ H2O þ C8N2H5 (phthalazinyl) þC6H5N2], 107 (C6H5Nþ2 ), 78(C6H5) .
3.6. Thermal data
The decomposition patterns of [CuL(OAc)(H2O)2] and [Cu(LH)(OAc)2H2O] are
summarized in table 3. As can be observed from the TG traces, both Cu(II) complexes
are stable to 200ꢁC. In both cases, the coordinated H2O and the CH3COOꢀ were lost at
about same temperature, ꢂ200ꢁC. The complex in which LH was a mono-anionic
ligand (L) retained this ligand to a temperature of 900ꢁC. This was expected because of
the stronger covalent attachment of L to Cu(II) in the former than a dative bond made
by LH to Cu(II) in the latter. The decomposition patterns agree with the structural
formulas suggested for the Cu(II) complexes.
3.7. Antifungal activity
All the compounds synthesized have been tested for their antifungal activity against
A. niger. Aspergillus niger is less likely to cause human disease than some other
Aspergillus species, but, if large amounts of spores are inhaled, a serious lung disease,
aspergillosis, can occur. Aspergillus niger is also one of the most common causes of
otomycosis, a fungal ear infection, which can cause pain, temporary hearing loss, and,
in severe cases, damage to the ear and tympanic membrane. Currently, the available
drug [19] is amphotericin B. In this study, amphotericin B has been used as control.
Amphotericin B is also commonly used in tissue cultures to prevent fungi from
contaminating cell cultures. Mammalian and fungal membranes both contain sterols, a
primary membrane target for amphotericin B. Because mammalian and fungal
membranes are similar in structure and composition, this is one mechanism by which
amphotericin B causes cellular toxicity. The objective of the present antifungal study
was to find the possibility of another potential drug comparable with the control but
less toxic. The results are presented in table 4. All the synthesized compounds exhibited
some antifungal activity. All the complexes, except that of Ni(II), showed more activity
than ligand. These complexes also disturb the respiration process of the cell and thus
block the synthesis of proteins, which restricts further growth of the organism. The